February 27 - March 2, 2007
Amelia Island Plantation
Amelia Island, Florida
CONFERENCE CHAIRPERSONS:
Rudolf H. Aebersold, Institute of Molecular Systems Biology, Zurich, Switzerland and Institute of Systems Biology, Seattle, WA
Richard M. Caprioli, Vanderbilt University, Nashville, TN
Matthias Mann, Max Planck Institute of Biochemistry, Martinsried, Germany
New molecular technologies in proteomics and their use in molecular pathology have significant clinical potential in the diagnosis, prognosis, and treatment of cancer. Although early in the discovery process, these technologies promise new insights into molecular aspects of disease, and ultimately, directly to patient care.
This conference presented the latest technologies, protocols, and applications involving proteomics in cancer research. Several sessions described the fundamental aspects of these technologies, their merits and limitations, and perspectives for future advances. In addition, several sessions were targeted to current applications of proteomics to cancer including discussions of basic experimental approaches, data acquisition and analysis, and the biological and clinical outcome of such studies.
The conference drew nearly 150 researchers from around the world, both novice and specialist. Sessions included new mass spectrometry (MS) technologies, imaging and other non-MS technologies, protein quantitation, tissue and bio-fluid analysis, post-translational modifications, signaling networks and drug target discovery, experimental design and statistical considerations, informatics, and several specific biological applications encompassing studies from mouse models to humans.
Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.